ARL14EP: A Potential Drug Target and Biomarker (G120534)

Target Name: ARL14EP

NCBI ID: G120534

ARL14EP

ARL14EP: A Potential Drug Target and Biomarker

ARL14EP (ARL1481) is a potential drug target and biomarker that has been identified in the scientific literature. It is a non-coding RNA molecule that has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. The unique structure and function of ARL14EP make it an attractive target for drug development.

Structure and Function

ARL14EP is a small non-coding RNA molecule that consists of 198 amino acid residues. It has a unique structure that consists of a long terminal extension, a 5' end, and a 3' end. The 5' end of ARL14EP contains a splicing enhancer element that is responsible for driving splicing of the RNA molecule. The 3' end of ARL14EP contains a stem-loop region that is involved in the formation of a stem-loop-like structure.

ARL14EP has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. It has been shown to be involved in the formation of tight junctions, which are a type of cell-cell adhesion that is essential for the proper functioning of various physiological processes.

In addition to its role in cell adhesion, ARL14EP has also been shown to play a role in the regulation of cell migration. It has been shown to be involved in the migration of various cell types, including cancer cells. This suggests that ARL14EP may be a potential drug target for cancer therapies.

ARL14EP has also been shown to play a role in the regulation of cell invasion. It has been shown to be involved in the invasion of various cell types, including cancer cells. This suggests that ARL14EP may be a potential drug target for anti-cancer therapies.

Drug Target Potential

The unique structure and function of ARL14EP make it an attractive target for drug development. Its involvement in various cellular processes, including cell adhesion, migration, and invasion, makes it an attractive target for drugs that can modulate these processes.

ARL14EP has been shown to be involved in the formation of tight junctions, which are a type of cell-cell adhesion that is essential for the proper functioning of various physiological processes. tight junctions are critical for the proper functioning of various physiological processes, including the regulation of ion and solute transport, as well as the regulation of cell signaling pathways.

ARL14EP has also been shown to play a role in the regulation of cell migration. It has been shown to be involved in the migration of various cell types, including cancer cells. This suggests that ARL14EP may be a potential drug target for anti-cancer therapies.

In addition to its potential as a drug target, ARL14EP has also been shown to be a potential biomarker. Its unique structure and function make it an attractive target for biomarker development. By identifying ARL14EP as a potential drug target and biomarker, researchers may be able to develop new diagnostic tests and therapies for a variety of diseases.

Conclusion

In conclusion, ARL14EP is a potential drug target and biomarker that has been identified in the scientific literature. Its unique structure and function make it an attractive target for drug development. The potential drug targets for ARL14EP include the regulation of cell adhesion, migration, and invasion, as well as the regulation of various physiological processes. Its potential as a biomarker makes it an attractive target for the development of new diagnostic tests and therapies for a variety of diseases. Further research is needed to fully understand the role of ARL14EP in

Protein Name: ADP Ribosylation Factor Like GTPase 14 Effector Protein

Functions: Through its interaction with ARL14 and MYO1E, may connect MHC class II-containing cytoplasmic vesicles to the actin network and hence controls the movement of these vesicles along the actin cytoskeleton in dendritic cells

The "ARL14EP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARL14EP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets